Live Breaking News & Updates on பி.சி. புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை ப்ரோக்ர்யாம்

, 2020
Today, IRICoR and Ovarian Cancer Canada are proud to announce the three winners of this competition, which aims to support research efforts related to the discovery of new treatments for women with ovarian cancer. A total
$2.3M will be invested over the next two (2) years, namely $1.15M from IRICoR and $1.15M from
 Ovarian Cancer
Canada s OvCAN initiative, largely funded by Health Canada.
The LeadAction Ovarian Cancer Competition is a powerful example of collaboration at its best. Together with IRICoR, a leader in the field of drug discovery, we invited two women with lived experience of ovarian cancer to the decision table to contribute firsthand insights, says Elisabeth Baugh, Chief Executive Officer, Ovarian Cancer Canada. Given the high caliber of these projects, we look forward to seeing results that help women with ovarian cancer live fuller, better and longer lives. ....

Nadine Beauger , Janice Chan , Desbois Mackenzie , Elisabeth Baugh , Canadian Cancer Society , Bc Cancer Immunotherapy Program , Centre Of Excellence , Institute For Research , Health Canada , Ovarian Cancer Canada , Canadian Leadaction Ovarian Cancer , Leadaction Ovarian Cancer Competition , Chief Executive Officer , Ovarian Cancer , Leadaction Ovarian Cancer , Cancer Canada , Communication Advisor , Public Relations , ஜானிஸ் சான் , எலிசபெத் பா , கனடியன் புற்றுநோய் சமூகம் , பி.சி. புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை ப்ரோக்ர்யாம் , மையம் ஆஃப் சிறப்பானது , நிறுவனம் க்கு ஆராய்ச்சி , ஆரோக்கியம் கனடா , ஓவாயரியந் புற்றுநோய் கனடா ,